Marijuana in the Workplace: Federal Rescheduling, Drug Testing, and Key Legal Updates

In this webinar, the speakers will provide a general update on recent changes regarding workplace marijuana issues and marijuana legalization laws. They will explore the implications of President Trump’s executive order from December 2025, which directs the Department of Justice to take steps to reschedule marijuana from a Schedule I to a Schedule III drug under the federal Controlled Substances Act. This webinar will address the effects this rescheduling may have on state marijuana legalization laws, considerations under the ADA and other state disability laws, as well as the practical implications for employers in managing their drug and alcohol policies and testing programs. Additionally, the webinar will examine how the federal rescheduling of marijuana affects employers regulated by federal law, such as those with DOT-regulated employees.